Blueprint Medicines Corporation Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (17)

Latest Posts

About This Stock More About This Stock
8 Stocks To Watch For Wednesday, Jan. 22
Article By: Benzinga
Wednesday, January 22, 2020 5:21 AM EDT
Wall Street expects Abbott Laboratories to report quarterly earnings at $0.95 per share on revenue of $8.26 billion before the opening bell.
In this article: BPMC, STLD, IBM, JNJ, ABT, TXN, BKR, NFLX
Read
Week In Review: Four China Biopharmas Announce $100+ Million Deals In First Week Of 2020
Article By: ChinaBio® Today
Saturday, January 11, 2020 4:11 PM EDT
Apollomics of Hangzhou announced a $189 million agreement to develop two GlycoMimetics novel E-selectin-based immunotherapies in China for leukemia. Apollomics will be responsible for developing uproleselan and GMI-1687.
In this article: LLY, GLYC, BPMC, ZLAB
Read
Week In Review: Hua Medicine Approved For $200 Million Hong Kong IPO
Article By: ChinaBio® Today
Saturday, June 9, 2018 4:46 PM EDT
Hua Medicine, a Beijing biopharma, announced its IPO application was accepted by the Hong Kong exchange. According to rumors, the company hopes to raise $200 million in the offering.
In this article: BPMC
Read
Blueprint Sinks, Loxo Rises After Trial Data On Potential Solid Tumor Treatment
Article By: The Fly
Monday, April 16, 2018 2:43 PM EDT
Shares of Blueprint Medicines are sliding after the company reported data over the weekend regarding its early-stage candidate in RET-altered tumors.
In this article: BPMC, LOXO
Read
Blueprint Medicines - Chart Of The Day
Article By: Jim Van Meerten
Thursday, April 20, 2017 5:37 PM EDT
Since the Trend Spotter signaled a buy on 2/27 the stock gained 25.96%.
In this article: BPMC
Read

PARTNER HEADLINES

Latest Tweets for $BPMC

No tweets yet!